WHO ICTRP trial

Prospective Randomized Controlled Trial to Evaluate the Effect of Adding…

JPRN-jRCTs031240597 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCTs031240597
Public title Prospective Randomized Controlled Trial to Evaluate the Effect of Adding Clostridium butyricum MIYAIRI 588 to Preoperative Adjuvant Chemotherapy with Immuno checkpoint inhibitor for Non-Small Cell Lung Cancer
Scientific title A Single-Center Prospective Randomized Controlled Exploratory Trial to Evaluate the Effect of Adding Clostridium butyricum MIYAIRI 588 to Preoperative Adjuvant Chemotherapy with Immuno checkpoint inhibitor for Non-Small Cell Lung Cancer
Primary sponsor Suzuki Hidemi
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase 2
Conditions Patients who receive neoadjuvant chemotherapy with immune checkpoint inhibitors for NSCLC non small cell lung cancer;non small cell lung cancer
Interventions Adding clostridium butyricum miyairi to neoadjuvant chemotherapy with immune checkpoint inhibitor.;non small cell lung cancer, neoadjuvant chemotherapy, immune checkpoint inhibitor, clostridium butyricum miyairi
Registration date Aug 1, 2025
Target size 24
Registry page jrct.mhlw.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations